Mayo Clinic
The radiopharmaceutical, already approved for SSRT-expressing GEP-NETs, may be a new option in meningioma if future research validates findings from this small study.
FDA Platform Designation Program Could Ease Path to Market for Gene-Editing Therapies
In a draft guidance, the agency outlined how the well-understood and reproducible components of genetic medicines could qualify as platform technologies.
Mayo Clinic Launches Four-Pillar Strategy to Bring Omics Into Patient Care
With the omics strategy, the health system aims to integrate precision medicine, genomic testing, and data into patient care.
Early is Good Partners With Mayo Clinic on Prostate Cancer Test Development
The test could run on the company's Multi-Omics Integration Platform, which is designed to simultaneously detect a range of molecules in blood or urine.
Combination of Polygenic, Social, Clinical Factors Improve Prediction of Heart Disease Risk
A model of these three measures improved heart disease risk predictions over any one measure, researchers reported at the American College of Cardiology meeting.